Evaluation of Cardiags Trimod for Analysis of Cardiac Activity
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.
Also called NCT05162599
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 120 participants
- Sponsor
- CARDIAGS
- Registry
-
NCT05162599
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- France
- Registry status
- Completed
Technical summary
Registry record NCT05162599. Allocation not applicable; no masking; primary purpose diagnostic. Start 2022-06-08 (actual); primary completion 2023-06-08 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation of Cardiags Trimod for Analysis of Cardiac Activity
- Acronym
- EVALTRIMOD
- Condition
- Murmur, Heart
- Condition
- Rhythm; Abnormal
- Intervention (Device)
- Diagnostic study, experimental evaluative cross-sectional study
- Lead sponsor
- CARDIAGS
Record details
- Record id
cardio:ct-nct05162599- Content hash
53a039a4e53d538797085726ef8a1d76c1cebfd96eecce169bd1b2c24c4dad12